Loss of the TRPM4 channel in humans causes immune dysregulation with defective monocyte migration - 05/09/24
Abstract |
Background |
TRPM4 is a broadly expressed, calcium-activated, monovalent cation channel that regulates immune cell function in mice and cell lines. Clinically, however, partial loss- or gain-of-function mutations in TRPM4 lead to arrhythmia and heart disease, with no documentation of immunologic disorders.
Objective |
To characterize functional cellular mechanisms underlying the immune dysregulation phenotype in a proband with a mutated TRPM4 gene.
Methods |
We employed a combination of biochemical, cell biological, imaging, omics analyses, flow cytometry, and gene editing approaches.
Results |
We report the first human cases to our knowledge with complete loss of the TRPM4 channel, leading to immune dysregulation with frequent bacterial and fungal infections. Single-cell and bulk RNA sequencing point to altered expression of genes affecting cell migration, specifically in monocytes. Inhibition of TRPM4 in T cells and the THP-1 monocyte cell line reduces migration. More importantly, primary T cells and monocytes from TRPM4 patients migrate poorly. Finally, CRISPR knockout of TRPM4 in THP-1 cells greatly reduces their migration potential.
Conclusion |
Our results demonstrate that TRPM4 plays a critical role in regulating immune cell migration, leading to increased susceptibility to infections.
Le texte complet de cet article est disponible en PDF.Key words : TRPM4, immune dysregulation, monocyte, migration, loss of function, infections
Abbreviations used : APC, CBA, DEG, GFP, GI, gRNA, IRB, NC, NMDG, 9-Phe, RNA-Seq, SOCE, TG
Plan
Vol 154 - N° 3
P. 792-806 - septembre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?